WELCOME

CAMP PODS is a webinar series, consisting of 10 one-hour sessions that will take place from January to November 2022 on the 1st Thursday of each month with the exception of our first session, which will take place on January 13th.

The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed.  Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.

Overall Learning Objectives:

By the end of the webinar series, an audience member will:

  1. Establish a strong Oncology Education Network
  2. Compare ideas, thoughts and common challenges
  3. Identify gaps and find team solutions for improving patient care
  4. Integrate pathology and oncology practices

2022 AGENDA

Thursday, January 13th, 2022
Chair: Dr. Diana Ionescu  – Access the Virtual Conference Recorded Session
10:00am – 10:30am PST Pathologic and Molecular Classification of Gastric Carcinomas Dr. Celia Marginean
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
At the end of this talk, the participant will be familiar with:​
1. Most updated histological classification of gastric cancer ​
2. Current molecular classifications of GC​
3. Practical applications of molecular classifications of GC​
4. Correct interpretation and scoring criteria for most common IHC used in GC

2021 AGENDA

All recorded sessions are password protected. If you don’t have a password, please contact charmaine@haymatick.com to get access to CAMPPOD recordings.

Thursday, January 14th, 2021 –  Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Deep Learning in Pathology – Connecting Morphology with Genome Dr. Stephen Yip
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Understand the fundamentals as well as evolving concept of deep learning
2. Appreciate the potentials of deep learning in medicine and particularly in the practice of pathology
3. Build a Deep learning- integrative academic pathology program
Thursday, February 4, 2021 –  Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Molecular Subtyping of Urothelial Carcinoma: Pathological Correlation and Clinical Impact Dr. Peter Black & Dr. Gang Wang
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:

  1. Appreciate the evolving concept of molecular subtypes in urothelial carcinoma.
  2. Understand the pathological variants of urothelial carcinoma, their molecular correlation, and the impact in the practice of pathology
  3. Appreciate the potential clinical application of the molecular subtypes in urothelial carcinoma
Thursday, March 4, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu 
10:00am – 10:30am PST Nurse Navigator in Oncology: Luxury or Necessity? Ms. Kelly Zibrik
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Describe the role of the Nurse Navigator in thoracic oncology at BC Cancer Vancouver.
2. Recognize current challenges in triage workflow in relation to pathology practice.
3. Specify opportunities for improving molecular-biomarker turnaround times for cancer patients.
4. Identify key actions that pathologists can do to improve patient triage in oncology.
Thursday, May 6, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu 
10:00am – 10:30am PST Fast Forward to Finding and Treating Fusions (with a focus on Colorectal Cancers) Dr. Eric Chen & Dr. Jaclyn Hechtman
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Describe the frequency of NTRK fusions across cancers
2. Understand molecular subtype of colorectal carcinoma enriched in kinase fusions
3. List and compare methods of detecting NTRK fusions
4. Share Canadian experiences in treating patients with NTRK fusion-positive colorectal cancer.
Thursday, June 3, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
11:00am – 11:30am PST Update on First-Line Immunotherapy and PD-L1 Testing in HNSCC Dr. Denis Soulières
11:30am – 12:00pm PST Questions & Answers
Presentation Learning Objectives:
1. Identify key points on the selection of therapy in the first-line setting in R/M HNSCC
2. Understand the value of PD-L1 testing in this setting
3. Specify unmet medical needs for this population
Thursday, August 5, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST ASCO 2021 Pathology Needed for Adjuvant Therapy Dr. Barb Melosky &

Dr. Marie-Hélène Denault
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
1. Review current management of resected NSCLC
2. Discuss the recent data of adjuvant EGFR-TKI use in resected patients
3. Explore updates from ASCO 2021 on adjuvant EGFR TKI studies and for Wild Type patients
Thursday, September 2, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Personalized Treatment Strategies in Metastatic Colorectal Cancer Dr. Sharlene Gill
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:

1. To review the current management of metastatic colorectal cancer
2. To review the established biomarker driven approaches for the treatment of metastatic colorectal cancer
3. To discuss the role of testing strategies and emerging biomarkers in CRC
Thursday, October 7, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Interpretation of Residual Cancer After Neoadjuvant Treatment for Breast Cancer Dr. W. Fraser Symmans
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
1. Learn how to measure and report residual disease after neoadjuvant treatment
2. Understand the prognostic meaning of response to neoadjuvant treatment
3. Understand the relevance of response in the context of molecular subtypes of disease and in the context of contemporary treatment planning
Thursday, November 4, 2021
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Novel Biomarkers TBD
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
Thursday, December 2, 2021
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Presentation TBD
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
Thursday, January 14th, 2021 –  Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Deep Learning in Pathology – Connecting Morphology with Genome Dr. Stephen Yip
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Understand the fundamentals as well as evolving concept of deep learning
2. Appreciate the potentials of deep learning in medicine and particularly in the practice of pathology
3. Build a Deep learning- integrative academic pathology program
Thursday, February 4, 2021 –  Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Molecular Subtyping of Urothelial Carcinoma: Pathological Correlation and Clinical Impact Dr. Peter Black & Dr. Gang Wang
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:

  1. Appreciate the evolving concept of molecular subtypes in urothelial carcinoma.
  2. Understand the pathological variants of urothelial carcinoma, their molecular correlation, and the impact in the practice of pathology
  3. Appreciate the potential clinical application of the molecular subtypes in urothelial carcinoma
Thursday, March 4, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu 
10:00am – 10:30am PST Nurse Navigator in Oncology: Luxury or Necessity? Ms. Kelly Zibrik
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Describe the role of the Nurse Navigator in thoracic oncology at BC Cancer Vancouver.
2. Recognize current challenges in triage workflow in relation to pathology practice.
3. Specify opportunities for improving molecular-biomarker turnaround times for cancer patients.
4. Identify key actions that pathologists can do to improve patient triage in oncology.
Thursday, May 6, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu 
10:00am – 10:30am PST Fast Forward to Finding and Treating Fusions (with a focus on Colorectal Cancers) Dr. Eric Chen & Dr. Jaclyn Hechtman
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
As a result of attending this session the participant will be able to:
1. Describe the frequency of NTRK fusions across cancers
2. Understand molecular subtype of colorectal carcinoma enriched in kinase fusions
3. List and compare methods of detecting NTRK fusions
4. Share Canadian experiences in treating patients with NTRK fusion-positive colorectal cancer.
Thursday, June 3, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
11:00am – 11:30am PST Update on First-Line Immunotherapy and PD-L1 Testing in HNSCC Dr. Denis Soulières
11:30am – 12:00pm PST Questions & Answers
Presentation Learning Objectives:
1. Identify key points on the selection of therapy in the first-line setting in R/M HNSCC
2. Understand the value of PD-L1 testing in this setting
3. Specify unmet medical needs for this population
Thursday, August 5, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST ASCO 2021 Pathology Needed for Adjuvant Therapy Dr. Barb Melosky &

Dr. Marie-Hélène Denault
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
1. Review current management of resected NSCLC
2. Discuss the recent data of adjuvant EGFR-TKI use in resected patients
3. Explore updates from ASCO 2021 on adjuvant EGFR TKI studies and for Wild Type patients
Thursday, September 2, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Personalized Treatment Strategies in Metastatic Colorectal Cancer Dr. Sharlene Gill
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:

1. To review the current management of metastatic colorectal cancer
2. To review the established biomarker driven approaches for the treatment of metastatic colorectal cancer
3. To discuss the role of testing strategies and emerging biomarkers in CRC
Thursday, October 7, 2021 – Access the Virtual Conference Recorded Session
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Interpretation of Residual Cancer After Neoadjuvant Treatment for Breast Cancer Dr. W. Fraser Symmans
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
1. Learn how to measure and report residual disease after neoadjuvant treatment
2. Understand the prognostic meaning of response to neoadjuvant treatment
3. Understand the relevance of response in the context of molecular subtypes of disease and in the context of contemporary treatment planning
Thursday, November 4, 2021
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Novel Biomarkers TBD
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:
Thursday, December 2, 2021
Chair: Dr. Diana Ionescu
10:00am – 10:30am PST Presentation TBD
10:30am – 11:00am PST Questions & Answers
Presentation Learning Objectives:

2020 Recorded Sessions

CAMP PODS Presentation #1 September 10th, 2020 – What Oncologists Want – An Oncologic Pathology Hotline

CAMP PODS Presentation #2 October 1st, 2020 – Cost Effective Biomarker Testing in Lung Cancer: The Alberta Experiment

CAMP PODS Presentation #3 November 5th, 2020 – Point of Care Molecular Testing